The global Cerebrospinal Fluid (CSF) Leak Market size is expected to reach USD 2.31 Billion in 2028 and register a revenue CAGR of 4.8% over the forecast period, according to latest report by Reports and Data. Factors that are expected to drive market revenue growth include increasing number of people suffering from neurological diseases, a surge in demand for minimally invasive surgeries, and rapid advancements in healthcare facilities.

Growth of the market is being fueled by rising prevalence of hydrocephalus and subsequent increase in incidence of ventriculomegaly across the globe. Furthermore, implementation of advanced sensors in cerebrospinal fluid devices due to rapid advancements in technology has improved quality of diagnosis. This is another major factor to support revenue growth of the market.

Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.reportsanddata.com/download-free-sample/1224

Some Key Highlights from the Report

• In April 2021, Biocept announced complete commercial launch of CNSide cerebrospinal fluid assay to address the needs of patients with metastatic brain cancer. Initially introduced in January 2020, the assays can provide a timely and accurate method to diagnose disease, identify actionable biomarkers, and assess response to therapy impacting quality of life and life expectancy.
• The shunts segment is expected to register robust revenue growth rate during the forecast period owing to increasing numbers of revision shunt surgeries being performed due to shunt malfunction and infection. Shunts are found to be useful for diversion of cerebrospinal fluid in a controlled manner away from the central nervous system (CNS) fluid compartments. It provides an alternative pathway for fluid flow.
• The pediatric segment accounted for significant revenue share in 2020, which can be attributed to rising incidence of congenital hydrocephalus and a surge in shunting procedures performed in pediatric population. Hydrocephalus is a common congenital condition in children, and it occurs in one or two babies per 1000 live births.
• Hospital segment accounted for largest revenue share in 2020 and is anticipated to grow at the highest rate during the forecast period, owing to a large number of in-hospital cases related to cerebrospinal fluid management in elderly population. Additionally, treatment of this disease requires sophisticated equipment and proper infrastructure which are generally available in hospitals.
• The market in Asia-Pacific is expected to register fastest revenue growth rate during the forecast period. Increasing prevalence of congenital hydrocephalus in China, rising geriatric population in different countries in the region, and growing medical tourism in India and several other countries are driving revenue growth of this regional market. Increasing awareness about neurological diseases and related treatment options in the region, coupled with rising incidence of stroke, is also creating increased need for cerebrospinal fluid management.

Competitive Outlook of the Global Cerebrospinal Fluid (CSF) Leak Market

The globla Cerebrospinal Fluid (CSF) Leak market study focuses on the revenue growth trajectories of the leading companies in this market. This section of the report throws light on the highly competitive landscape of the Cerebrospinal Fluid (CSF) Leak market, pointing out the major players. The report further discusses the strategic initiatives undertaken by each of these market players, including mergers acquisitions, collaborations, joint ventures, new product launches, new business deals, and technological innovations.

Top Companies Profiled in the Report:

Medtronic PLC, BeckerSmith Medical Inc., Integra Lifesciences, B. Braun Melsungen, Spiegelberg GmbH Co. KG, Sophysa S.A., Natus Medical Incorporated, Moller Medical GmbH, Delta Surgical, and DePuy Synthes.

Inquiry Before Buying @ https://www.reportsanddata.com/inquiry-before-buying/1224

The report is inclusive of product type outlook, application spectrum, end-use outlook, technology landscape, regional market analysis, and competitive overview.

Cerebrospinal Fluid (CSF) Leak Market Segmentation:

Type Outlook (Revenue, USD Billion; 2018–2028)

• Shunts
• Ventriculoperitoneal Shunts
• Ventriculoatrial Shunts
• Lumboperitoneal Shunts
• Ventriculopleural Shunts
• Fixed Valve Shunts
• Adjustable Valve Shunts
• External Drainage Systems
• External Ventricular Drainage Systems
• Lumbar Drainage Systems

Patient Type Outlook (Revenue, USD Billion; 2018–2028)

• Pediatric
• Adult
• Geriatric

End-Use Outlook (Revenue, USD Billion; 2018–2028)

• Hospitals
• Clinics
• Others

Geographic Segment Covered in the Report:

The Cerebrospinal Fluid (CSF) Leak report provides information about the market area, which is further subdivided into sub-regions and countries/regions. In addition to the market share in each country and sub-region, this chapter of this report also contains information on profit opportunities. This chapter of the report mentions the market share and growth rate of each region, country, and sub-region during the estimated period.

• North America (USA and Canada)
• Europe (UK, Germany, France and the rest of Europe)
• Asia Pacific (China, Japan, India, and the rest of the Asia Pacific region)
• Latin America (Brazil, Mexico, and the rest of Latin America)
• Middle East and Africa (GCC and rest of the Middle East and Africa)

Request customization of the report @ https://www.reportsanddata.com/request-customization-form/1224

Thank you for reading our report. Customization of this report is available as per the client’s requirements. Please connect with us to know more about the report and our team will ensure you get the report tailored according to your needs.

Get Explore Latest Research Report by Reports and Data:

Antiglaucoma Eye Drops Market @ https://www.biospace.com/article/antiglaucoma-eye-drops-market-size-growth-demand-industry-outlook-2021-2028/

Thoracic Catheters Market @ https://www.biospace.com/article/growing-trend-toward-robotic-surgery-is-gaining-traction-as-a-result-of-increased-use-of-3d-visualization-propelling-market-growth-reports-and-data/

EEG and ECG Biometrics Market @ https://www.biospace.com/article/rising-opportunities-for-players-operating-in-the-global-eeg-and-ecg-biometrics-market/

Gastrointestinal Cancer Drugs Market @ https://www.biospace.com/article/ongoing-trends-in-the-gastrointestinal-cancer-drugs-market-and-forecast-analysis-by-2021-2028/

Bone Allografts and Xenografts Market @ https://www.biospace.com/article/bone-allografts-and-xenografts-industry-size-2021-2028-rising-demand-for-a-variety-of-orthopaedics-operations-is-one-of-the-main-factors-expected-to-drive-market-revenue-growth-says-reports-and-data/

Targeted RNA Sequencing Market @ https://www.biospace.com/article/targeted-rna-sequencing-market-size-share-growth-trends-growth-analysis-by-2021-2028/

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, TouchPoints, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provide our clients with the ability to secure an edge over their respective competitors.

Contact Us:

John W

Head of Business Development

Reports and Data | Web: www.reportsanddata.com

Direct Line: +1-212-710-1370

E-mail: sales@reportsanddata.com